PharmiWeb.com - Global Pharma News & Resources
02-Jan-2024

Metabolomics Market Growing at a CAGR of 14.9% Say, Roots Analysis

The metabolomics market is estimated to be worth $173 million in 2022 and is expected to grow at compounded annual growth rate (CAGR) of 14.9% during the forecast period 2023 to 2035.

Scientific fields involved in high throughput measurement of biological molecules are referred with the suffix-omics including, nutrigenomics, transcriptomics, genomics, proteomics and metabolomics testing. Genomics is the study of genetic material within a cell, and transcriptomics is the study of gene activity in different cells. Likewise, metabolomics testing involves the study of by products of metabolism. Although, metabolomics testing is a relatively new field, results generated through studies directly reflect the molecular phenotype of cells or tissues, thus making it a promising tool than its counterparts for preventive healthcare and pharmaceutical industries.

Metabolomics testing can be defined as the process of large-scale, high-throughput analysis of small molecules found in cells, tissues, biological fluids, or organisms. Since, several reactions occur continuously within cells, metabolite concentrations are thought to be very dynamic and can change drastically from one stage in the process to the next which makes analysis of metabolome challenging. However, research related to metabolites is essential to increase the understanding of molecular level interactions, functions, modifications and regulations in cells, therefore, the field of metabolomics plays a vital role in biomarker discovery for early disease diagnosis and prognosis as well as for drug discovery and development processes. Various steps involved in metabolic analysis and metabolome profiling have been depicted below.

Untargeted, namely discovery metabolomics, represents the unbiased analysis of small molecules present in a biological sample, under specific conditions. It aims to detect the alterations in the global metabolomic profiles of control and test groups to generate a hypothesis. Untargeted metabolomics employs a top-down approach to analyze the entire metabolic network concerning a specific biological condition. Further,it has been successfully used to identify the severity of different types of asthma.

 In fact, since 2000, more than 70 metabolomics company offering metabolomics services have been established. Amidst growing competition in the metabolomics market, the implementation of cutting-edge tools and technologies, such as artificial intelligence, big data analytics, deep learning, machine learning and quantum computing, serves to differentiate the offerings of stakeholders

Currently, more than 170 players are engaged in offering metabolic analysis and metabolome profiling services across the globe, most of the service providers engaged in this domain (~50%) are headquartered in North America, followed by Europe and Asia. Pasted below is a donut chart, showing the regional distribution of companies / organizations offering metabolomics services.

However, due the various challenges associated with successful conduct of metabolomics studies, including high cost of instruments, equipment maintenance, and the requirement of high-end expertise, several players in the pharmaceutical industry are outsourcing their metabolite profiling-related needs to capable, specialty service providers. This has resulted in the emergence of many companies offering metabolomics services over the past few years. In fact, since 2000, more than 70 players offering such services have been established. Amidst growing competition, the availability of cutting-edge tools and technologies have emerged as a differentiating factor. This has caused many service providers to actively expand their service portfolios, either through strategic acquisitions or entering into service alliances with other metabolomic companies   Key companies engaged in metabolomics market (which have also been profiled in this market report; the complete list of companies is available in the full report) include biocrates life sciences, Creative Proteomics, DNA Xperts, Eremid Research Services, Human Metabolome Technologies (HMT), Metabo Profile, Metabolon, MS-Omics, Novelgene Technologies and Synbio Technologies. This metabolomics market report includes an easily searchable excel database of all the metabolomics CRO providing metabolomics services, worldwide.

Read more https://www.rootsanalysis.com/reports/metabolomics-services-market.html

 

Editor Details

Last Updated: 12-Jan-2024